AstraZeneca ends work on cardio drug; Lisata and Qilu terminate deal
AstraZeneca ends work on cardio drug; Lisata and Qilu terminate deal
Body unavailable. Use the original source.
AstraZeneca ends work on cardio drug; Lisata and Qilu terminate deal
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.